Outset Medical (OM) Resumes Shipment of Tablo Systems for Home Use, Reports Second Quarter 2022 Financial Results and Provides 2022 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/14/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Goldman Sachs tech conference highlights AI spending outlook
- Dell shares surge on record AI server bookings
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- 'No panic anywhere' may be the problem, BofA strategists warn
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Outset Medical Inc. (OM) to Resume Trading at 10:30 a.m.
August 1, 2022 10:15 AM EDTOutset Medical Inc. (NASDAQ: OM) to Resume Trading at 10:30 a.m.
Outset Medical Inc. (OM) Misses Q2 EPS by 13c
August 1, 2022 10:04 AM EDTOutset Medical Inc. (NASDAQ: OM) reported Q2 EPS of ($0.77), $0.13 worse than the analyst estimate of ($0.64). Revenue for the quarter came in at $25.1 million versus the consensus estimate of $29.22 million.
GUIDANCE:
Outset Medical Inc. sees FY2022 revenue of $105-110 million, versus the... More
Outset Medical Inc. (OM) Halted, News Pending
August 1, 2022 9:37 AM EDTOutset Medical Inc. (NASDAQ: OM) Halted, News Pending
... MoreCowen Reiterates Outperform Rating on Outset Medical Inc. (OM), Comments on FDA Clearance
August 1, 2022 8:58 AM EDTCowen analyst Joshua Jennings reiterated an Outperform rating and $33.00 price target on Outset Medical Inc. (NASDAQ: OM).
The analyst comments "OM Has Received a New 510(k) Clearance for the Tablo Hemodialysis System. In a decision dated July 29, 2022, the FDA cleared a new 510(k)... More
Stifel on Outset Medical Inc. (OM): 'At Last, A Big Sigh of Relief As FDA Terms Tablo Catch-Up Filing As “Substantially-Equivalent”'
August 1, 2022 8:57 AM EDTStifel analyst Rick Wise reiterated a Buy rating and $24.00 price target on Outset Medical Inc. (NASDAQ: OM).
The analyst comments "Last Friday, Outset received a positive FDA update on its Tablo catch-up 510K filing, with the agency providing a substantially-equivalent decision on the filing.... More
Outset Medical Inc. (OM) Gains 6% Premarket; Cowen Cites FDA Clearance - Bloomberg
August 1, 2022 8:55 AM EDTOutset Medical Inc. (NASDAQ: OM) Gains 6% Premarket; Cowen Cites FDA Clearance - Bloomberg
... More